Grifols, the Spanish pharmaceutical company, is currently embroiled in a legal battle against Gotham City Research in the United States. The lawsuit accuses Gotham of conspiring to manipulate Grifols' stock price downward. In response, Grifols has engaged prominent legal firms, including Uría and CMS, as well as a law firm associated with Lionel Messi, to bolster its defense. Meanwhile, Gotham City Research has filed a motion in a New York federal court seeking to dismiss the lawsuit. The ongoing situation reflects the heightened scrutiny and challenges facing Grifols, which has been struggling with a decline in investor confidence and stock performance, exacerbated by aggressive short-selling tactics from entities like Ako Capital.
Gotham pide al tribunal federal de Nueva York que archive la demanda de Grifols https://t.co/ZIou9MIGB6
US short seller Gotham City Research asked a judge in New York to dismiss a lawsuit accusing it of conspiring to drive down shares in Grifols. https://t.co/2b6iyHvqqk
ÚLTIMA HORA | Gotham mueve ficha para que la justicia de EEUU desestime la demanda que le puso Grifols https://t.co/PH53zNR4Te